Changli Du
Impact in
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
-
- Nanoplatforms for cancer theranostics
- Graphene and Nanomaterials Applications
Papers in
-
- Nanoplatforms for cancer theranostics 4
-
- Cancer therapeutics and mechanisms 1
- Co-authors
- Yueqing Gu (6 shared papers)Shunan Wan (6 shared papers)Lingling Shan (4 shared papers)Samuel Achilefu (3 shared papers)Junmei Tian (3 shared papers)Dawei Deng (1 shared paper)Jie Cao (1 shared paper)Zhiyu Qian (3 shared papers)
- Journals
- Biomaterials (2 papers)Contrast Media & Molecular Imaging (2 papers)Molecular Imaging and Biology (1 paper)Frontiers in Pharmacology (1 paper)Cancer Research (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Changli Du
8 papers receiving 419 citations
Peers
Comparison fields: 5 of 71
- Biomaterials 196
- Biomedical Engineering 170
- Molecular Medicine 17
- Molecular Biology 186
- Cancer Research 36
Countries citing papers authored by Changli Du
This map shows the geographic impact of Changli Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Changli Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Changli Du more than expected).
Fields of papers citing papers by Changli Du
This network shows the impact of papers produced by Changli Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Changli Du. The network helps show where Changli Du may publish in the future.
Co-authors
The 22 scholars most cited alongside Changli Du, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 210 | |
| 2 | 2013 | 74 | |
| 3 | 2011 | 44 | |
| 4 | 2012 | 31 | |
| 5 | 2022 | 27 | |
| 6 | 2012 | 20 | |
| 7 | 2014 | 14 | |
| 8 | 2012 | 1 |
About Changli Du
Changli Du is a scholar working on Biomedical Engineering, Molecular Biology, Cardiology and Cardiovascular Medicine, Oncology and Biomaterials, having authored 8 papers that have together received 421 indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (4 papers), Cancer Research and Treatments (2 papers), Lanthanide and Transition Metal Complexes (2 papers), Nanoparticle-Based Drug Delivery (2 papers), Chemotherapy-induced cardiotoxicity and mitigation (2 papers), Cancer, Hypoxia, and Metabolism (1 paper), Cancer therapeutics and mechanisms (1 paper) and Neuropeptides and Animal Physiology (1 paper). The work is most often cited by research in Biomaterials (196 citations), Biomedical Engineering (170 citations), Molecular Medicine (17 citations), Molecular Biology (186 citations) and Cancer Research (36 citations). Changli Du has collaborated with scholars based in China and United States. Frequent co-authors include Yueqing Gu, Shunan Wan, Lingling Shan, Samuel Achilefu, Junmei Tian, Dawei Deng, Jie Cao, Zhiyu Qian, Sisi Cui and Guangji Wang. Their work appears in journals such as Biomaterials, Contrast Media & Molecular Imaging, Molecular Imaging and Biology, Frontiers in Pharmacology and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.